| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |